CME INFORMATION

Evaluations and CME Certificates

This year's evaluations are available HERE through June 9, 2026.

Target Audience

The intended audience for this activity is ophthalmologists and other healthcare professionals involved in the management of patients with ophthalmic diseases and disorders.

Learning Objectives: General Sessions

Upon successful completion of this activity, participants should be better able to:

  • Assess advances in vitreoretinal surgery
  • Examine real-world case presentations in surgical retinal disease management
  • Evaluate contemporary practice patterns and real-world outcomes in diabetic eye disease
  • Analyze advances and real-world performance of therapies for exudative (wet) age-related macular degeneration
  • Describe evolving clinical evidence and real-world application in the management of geographic atrophy
  • Recognize emerging strategies for intermediate AMD
  • Assess current medical retina challenges and their management
  • Summarize the latest evidence regarding biosimilars and on-label formulations of bevacizumab
  • Review controversies and real-world variability in retinal disease management
  • Describe the role of multimodal imaging in diagnosis, treatment planning, and monitoring across retinal diseases
  • Examine recent advances in uveitis management
  • Explore the role of genetic testing and precision medicine in today’s retina practice

Accreditation: In support of improving patient care, this activity has been planned and implemented by Vindico Medical Education and MUSC Storm Eye Institute. Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation: Vindico Medical Education designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty/Planner Disclosure Policy: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to mitigate and disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational uses of any products/devices.

Notice: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.